Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz, +11

The Journal of Experimental Medicine

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

Frederick Arce Vargas, Andrew J.S. Furness, Kevin Litchfield, +20

Cancer Cell

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Patrick Hayden, Claire Roddie, Peter Bader, +33

Annals of Oncology

Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity

Claire Roddie, Joel Paul, Reuben Benjamin, +7

Clinical Infectious Diseases

Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia

Claire Roddie, Karamjeet Sandhu, Eleni Tholouli, +28

New England Journal of Medicine

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Claire Roddie, Juliana Dias, Maeve O’Reilly, +24

Journal of Clinical Oncology

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

Claire Roddie, Lorna Neill, Wendy Osborne, +16

Blood Advances

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

Gloria Iacoboni, Vı́ctor Navarro, Ana África Martín‐López, +21

Journal of Clinical Oncology

A national service for delivering <scp>CD19 CAR‐T</scp>in large B‐cell lymphoma – The <scp>UK</scp> real‐world experience

Andrea Kühnl, Claire Roddie, Amy A. Kirkwood, +34

British Journal of Haematology

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

Thomas A. Fox, Ethan Troy‐Barnes, Amy A. Kirkwood, +16

British Journal of Haematology

ImmunohematologyImmunologyPathologySevere Covid‐19Covid-19 Epidemiology +20